Group 1 - The market reacted sharply to Cigna's second quarter 2025 report, but the reaction is considered excessive [1] - Cigna is currently trading at a price that may not reflect its underlying value [1] Group 2 - The article emphasizes the importance of thorough analysis in uncovering hidden value in companies [1]